secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001437749-25-001949
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart appoints Kevin Finney to board; Robert Yedid resigns
-----------------------------------------------------------

- Kevin Finney appointed to Vaxart board effective Jan 28, 2025; will serve on Audit and Nominating/Governance committees.
- Robert A. Yedid resigned from board on Jan 28, 2025 for personal reasons; no disagreement with the company.
- Elaine J. Heron appointed to Compensation Committee effective Jan 28, 2025.
- Finney is CEO/President of Autobahn Therapeutics and brings 35 years of biotech leadership experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774925001949/0001437749-25-001949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774925001949/vxrt20250127_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-001949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer